NEW YORK, Nov. 9 (GenomeWeb News) - PerkinElmer disclosed the purchase price for its previously announced tender offer after markets closed yesterday.
As GenomeWeb News reported yesterday afternoon, PerkinElmer received consents from its noteholders approving its cash tender offer for outstanding notes.
PerkinElmer anticipates Nov. 14 as the initial settlement date.
Holders who tender notes prior to the settlement date will receive total consideration per $1,000 principal amount of notes tendered of $1,119.64. This includes the consent payment of $20 and accrued and unpaid interest up to the payment date.
Holders who tender notes between the settlement date and expiration date of Nov.23, 9:00am, will receive total consideration per $1,000 principal amount of notes tendered of $1,118.65. This also includes the consent payment and accrued and unpaid interest.
The purchase price was calculated with the bid-side price of the US Treasury Note as indicated on Bloomberg screen PX5 at 2:00pm New York City time yesterday, the company said.
The company also said today that $269.9 million, or 99.6% of the aggregate outstanding principal amount of notes was validly tendered. The company had said 96% yesterday.